Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Local and systemic tolerability of a 2'O-methoxyethyl antisense oligonucleotide targeting interleukin-4 receptor-α delivery by inhalation in mouse and monkey.

Fey RA, Templin MV, McDonald JD, Yu RZ, Hutt JA, Gigliotti AP, Henry SP, Reed MD.

Inhal Toxicol. 2014 Jul;26(8):452-63. doi: 10.3109/08958378.2014.907587. Epub 2014 Jun 16.

PMID:
24932560
2.

Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates.

Rigo F, Chun SJ, Norris DA, Hung G, Lee S, Matson J, Fey RA, Gaus H, Hua Y, Grundy JS, Krainer AR, Henry SP, Bennett CF.

J Pharmacol Exp Ther. 2014 Jul;350(1):46-55. doi: 10.1124/jpet.113.212407. Epub 2014 Apr 30.

3.

Medical office buildings--a marketing strategy.

Fey RA.

Trustee. 1991 Aug;44(8):21. No abstract available.

PMID:
10112171
4.

Identifying and responding to physicians' needs ... a marketing priority.

Fey RA.

Health Care Strateg Manage. 1987 Sep;5(9):12-5.

PMID:
10284483
5.

Hospitals and physicians battle together for market share.

Fey RA.

Health Care Strateg Manage. 1986 Oct;4(10):17-20.

PMID:
10280134

Supplemental Content

Support Center